Tests a canaloplasty device for open-angle glaucoma during cataract surgery
Tests a canaloplasty device in adults with open-angle glaucoma having cataract surgery.
Plain-language title generated from the registry record
Registry title: Clinical Trial to Evaluate the Safety and Effectiveness of a Canaloplasty Device in Subjects With Open-Angle Glaucoma
Key facts
- Where
- Santiago, ChileSee the site
Where in Chile
- Centro de la VisionSantiago, ChileTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- New World Medical, Inc.
- Trial code
- NCT05696561
- Record updated
- 27 February 2026
- Original description
Clinical Trial to Evaluate the Safety and Effectiveness of a Canaloplasty Device in Subjects with Open-Angle GlaucomaRead full original descriptionShow less
A Prospective, Multicenter, First in Human Clinical Trial to Evaluate the Safety and Effectiveness of the DF12 CANALOPLASTY AND TRABECULOTOMY SURGICAL SYSTEM in Subjects With Open-Angle Glaucoma Undergoing Cataract Surgery
Clinical Trial to Evaluate the Safety and Effectiveness of a Canaloplasty Device in Subjects with Open-Angle Glaucoma
Inclusion: Subjects qualifying for cataract surgery; Subjects with diagnosis of open-angle glaucoma in at least one eye with unmedicated IOP of 22-34 mmHg.
Exclusion: Patients who cannot be washed-out of IOP-lowering medications.